✦ LIBER ✦

Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertension (LIFE) study

✍ Scribed by Michael Hecht Olsen; Kristian Wachtell; Gareth Beevers; Björn Dahlöf; Richard B. Devereux; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Sverre E. Kjeldsen; Ole Lederballe-Pedersen; Lars H. Lindholm; Puneet Narayan; Markku S. Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel

Book ID: 116191568
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 314 KB
Volume: 157
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2008.08.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Crumbling of left ventricular hypertroph

Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [life] study)

✍ Franz H Messerli; Mandeep R Mehra 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Regression of hypertensive left ventricu

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial

✍ R.B. Devereux; B. Dahlof; E. Gerdts 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Correlates of pulse pressure reduction d

Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study)

✍ Eva Gerdts; Vasilios Papademetriou; Vittorio Palmieri; Kurt Boman; Hans Björnsta 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Body Build and Risk of Cardiovascular Ev

Body Build and Risk of Cardiovascular Events in Hypertension and Left Ventricular Hypertrophy. The LIFE (Losartan Intervention For Endpoint reduction in hypertension) Study

✍ G. de Simone; K. Wachtell; V. Palmieri 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Gender differences in systolic left vent

Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study)

✍ Eva Gerdts; Miguel Zabalgoitia; Hans Björnstad; Tage Lysbo Svendsen; Richard B D 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Cost-effectiveness of losartan-based the

Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

✍ McInnes, G; Burke, T A; Carides, G 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB